{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T20:59:22Z","timestamp":1793134762123,"version":"4.5.0"},"reference-count":41,"publisher":"Oxford University Press (OUP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,7,2]]},"DOI":"10.1093\/cid\/ciy064","type":"journal-article","created":{"date-parts":[[2018,1,26]],"date-time":"2018-01-26T15:09:57Z","timestamp":1516979397000},"page":"303-309","source":"Crossref","is-referenced-by-count":225,"title":["A Review of Combination Antimicrobial Therapy for Enterococcus faecalis Bloodstream Infections and Infective Endocarditis"],"prefix":"10.1093","volume":"67","author":[{"given":"Maya","family":"Beganovic","sequence":"first","affiliation":[{"name":"College of Pharmacy, University of Rhode Island, Kingston"},{"name":"Infectious Diseases Research Program, Providence Veterans Affairs Medical Center, Providence, Rhode Island"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan K","family":"Luther","sequence":"additional","affiliation":[{"name":"College of Pharmacy, University of Rhode Island, Kingston"},{"name":"Infectious Diseases Research Program, Providence Veterans Affairs Medical Center, Providence, Rhode Island"},{"name":"Center of Innovation in Long-Term Services and Supports, Providence Veterans Affairs Medical Center, Providence, Rhode Island"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis B","family":"Rice","sequence":"additional","affiliation":[{"name":"Rhode Island Hospital, Providence, Rhode Island, Providence, Rhode Island"},{"name":"Warren Alpert Medical School of Brown University, Division of Infectious Diseases, Providence, Rhode Island"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cesar A","family":"Arias","sequence":"additional","affiliation":[{"name":"Center for Antimicrobial Resistance and Microbial Genomics, Division of Infectious Diseases, Department of Internal Medicine and Department of Microbiology and Molecular Genetics, University of Texas Health Science Center at Houston (UTHealth) McGovern Medical School, Bogota, Colombia"},{"name":"Center for Infectious Diseases, UTHealth School of Public Health, Bogota, Colombia"},{"name":"Molecular Genetics and Antimicrobial Resistance Unit, International Center for Microbial Genomics, Universidad El Bosque, Bogota, Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J","family":"Rybak","sequence":"additional","affiliation":[{"name":"Anti-Infective Research Laboratory, Department of Pharmacy Practice, Eugene Applebaum College of Pharmacy and Health Sciences, Michigan"},{"name":"Department of Medicine, Division of Infectious Diseases, School of Medicine, Wayne State University, Michigan"},{"name":"Department of Pharmacy Services, Detroit Receiving Hospital, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerry L","family":"LaPlante","sequence":"additional","affiliation":[{"name":"College of Pharmacy, University of Rhode Island, Kingston"},{"name":"Infectious Diseases Research Program, Providence Veterans Affairs Medical Center, Providence, Rhode Island"},{"name":"Center of Innovation in Long-Term Services and Supports, Providence Veterans Affairs Medical Center, Providence, Rhode Island"},{"name":"Warren Alpert Medical School of Brown University, Division of Infectious Diseases, Providence, Rhode Island"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,1,30]]},"reference":[{"key":"key\n\t\t\t\t20180702005751_CIT0001","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1161\/CIRCULATIONAHA.113.002431","article-title":"A new era for treating Enterococcus faecalis endocarditis: ampicillin plus short-course gentamicin or ampicillin plus ceftriaxone: that is the question","volume":"127","author":"Miro","year":"2013","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20180702005751_CIT0002","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1161\/CIR.0000000000000296","article-title":"Infective endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications: a scientific statement for healthcare professionals from the American Heart Association","volume":"132","author":"Baddour","year":"2015","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20180702005751_CIT0003","first-page":"e394","article-title":"Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America","volume":"111","author":"Baddour","year":"2005","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20180702005751_CIT0004","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1574-6968.2006.00112.x","article-title":"Relationship between biofilm formation, the enterococcal surface protein (Esp) and gelatinase in clinical isolates of Enterococcus faecalis and Enterococcus faecium","volume":"256","author":"Di Rosa","year":"2006","journal-title":"FEMS Microbiol Lett"},{"key":"key\n\t\t\t\t20180702005751_CIT0005","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1099\/jmm.0.05038-0","article-title":"Incidence of virulence determinants in clinical Enterococcus faecium and Enterococcus faecalis isolates collected in Sardinia (Italy)","volume":"52","author":"Dupr\u00e8","year":"2003","journal-title":"J Med Microbiol"},{"key":"key\n\t\t\t\t20180702005751_CIT0006","doi-asserted-by":"crossref","first-page":"574","DOI":"10.7326\/0003-4819-146-8-200704170-00008","article-title":"Brief communication: treatment of Enterococcus faecalis endocarditis with ampicillin plus ceftriaxone","volume":"146","author":"Gavald\u00e0","year":"2007","journal-title":"Ann Intern Med"},{"key":"key\n\t\t\t\t20180702005751_CIT0007","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1128\/JCM.36.2.520-525.1998","article-title":"Comparative study of bacteremias caused by Enterococcus spp. with and without high-level resistance to gentamicin. The Grupo Andaluz para el estudio de las Enfermedades Infecciosas","volume":"36","author":"Caballero-Granado","year":"1998","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20180702005751_CIT0008","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1128\/AAC.39.9.1984","article-title":"Synergistic effect of amoxicillin and cefotaxime against Enterococcus faecalis","volume":"39","author":"Mainardi","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180702005751_CIT0009","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1128\/AAC.43.3.639","article-title":"Efficacy of ampicillin plus ceftriaxone in treatment of experimental endocarditis due to Enterococcus faecalis strains highly resistant to aminoglycosides","volume":"43","author":"Gavald\u00e0","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180702005751_CIT0010","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1093\/jac\/dkg360","article-title":"Efficacy of ampicillin combined with ceftriaxone and gentamicin in the treatment of experimental endocarditis due to Enterococcus faecalis with no high-level resistance to aminoglycosides","volume":"52","author":"Gavald\u00e1","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20180702005751_CIT0011","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1093\/cid\/cit052","article-title":"Ampicillin plus ceftriaxone is as effective as ampicillin plus gentamicin for treating Enterococcus faecalis infective endocarditis","volume":"56","author":"Fern\u00e1ndez-Hidalgo","year":"2013","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180702005751_CIT0012","doi-asserted-by":"crossref","first-page":"O1075","DOI":"10.1111\/1469-0691.12756","article-title":"Changes in the treatment of Enterococcus faecalis infective endocarditis in Spain in the last 15 years: from ampicillin plus gentamicin to ampicillin plus ceftriaxone","volume":"20","author":"Pericas","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"key\n\t\t\t\t20180702005751_CIT0013","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1161\/CIRCULATIONAHA.112.001170","article-title":"Enterococcus faecalis infective endocarditis: a pilot study of the relationship between duration of gentamicin treatment and outcome","volume":"127","author":"Dahl","year":"2013","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20180702005751_CIT0014","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1128\/JB.186.5.1221-1228.2004","article-title":"Role of class A penicillin-binding proteins in PBP5-mediated beta-lactam resistance in Enterococcus faecalis","volume":"186","author":"Arbeloa","year":"2004","journal-title":"J Bacteriol"},{"key":"key\n\t\t\t\t20180702005751_CIT0015","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/j.1469-0691.2010.03214.x","article-title":"Management of multidrug-resistant enterococcal infections","volume":"16","author":"Arias","year":"2010","journal-title":"Clin Microbiol Infect"},{"key":"key\n\t\t\t\t20180702005751_CIT0016","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1086\/521859","article-title":"Antimicrobial-associated risk factors for Clostridium difficile infection","volume":"46","author":"Owens","year":"2008","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180702005751_CIT0017","first-page":"DC06","article-title":"Screening for intestinal colonization with vancomycin resistant enterococci and associated risk factors among patients admitted to an adult intensive care unit of a large teaching hospital","volume":"10","author":"Amberpet","year":"2016","journal-title":"J Clin Diagn Res"},{"key":"key\n\t\t\t\t20180702005751_CIT0018","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1086\/666331","article-title":"Association between vancomycin-resistant enterococci bacteremia and ceftriaxone usage","volume":"33","author":"McKinnell","year":"2012","journal-title":"Infect Control Hosp Epidemiol"},{"key":"key\n\t\t\t\t20180702005751_CIT0019","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.1128\/AAC.00125-06","article-title":"Antibiotic-induced enterococcal expansion in the mouse intestine occurs throughout the small bowel and correlates poorly with suppression of competing flora","volume":"50","author":"Lakticov\u00e1","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180702005751_CIT0020","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1086\/382086","article-title":"Beta-lactam antibiotics and gastrointestinal colonization with vancomycin-resistant enterococci","volume":"189","author":"Rice","year":"2004","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180702005751_CIT0021","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1128\/AAC.01716-09","article-title":"Effect of ceftaroline on normal human intestinal microflora","volume":"54","author":"Panagiotidis","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180702005751_CIT0022","doi-asserted-by":"crossref","first-page":"3178","DOI":"10.1128\/AAC.03126-15","article-title":"Ampicillin in combination with ceftaroline, cefepime, or ceftriaxone demonstrates equivalent activities in a high-inoculum Enterococcus faecalis infection model","volume":"60","author":"Luther","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180702005751_CIT0023","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02235-16","article-title":"Pharmacodynamics of ceftaroline plus ampicillin against Enterococcus faecalis in an in vitro pharmacokinetic\/pharmacodynamic model of simulated endocardial vegetations","volume":"61","author":"Werth","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180702005751_CIT0024","doi-asserted-by":"crossref","first-page":"4042","DOI":"10.1128\/AAC.02481-12","article-title":"Treatment of high-level gentamicin-resistant Enterococcus faecalis endocarditis with daptomycin plus ceftaroline","volume":"57","author":"Sakoulas","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180702005751_CIT0025","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1093\/jac\/dkv007","article-title":"\u03b2-Lactam combinations with daptomycin provide synergy against vancomycin-resistant Enterococcus faecalis and Enterococcus faecium","volume":"70","author":"Smith","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20180702005751_CIT0026","doi-asserted-by":"crossref","first-page":"6064","DOI":"10.1128\/AAC.01760-12","article-title":"Combination therapy with ampicillin and daptomycin for treatment of Enterococcus faecalis endocarditis","volume":"56","author":"Sierra-Hoffman","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180702005751_CIT0027","doi-asserted-by":"crossref","first-page":"6213","DOI":"10.1128\/AAC.01563-13","article-title":"High-dose daptomycin therapy for left-sided infective endocarditis: a prospective study from the international collaboration on endocarditis","volume":"57","author":"Carugati","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180702005751_CIT0028","doi-asserted-by":"crossref","first-page":"3174","DOI":"10.1128\/AAC.06439-11","article-title":"Evaluation of standard- and high-dose daptomycin versus linezolid against vancomycin-resistant Enterococcus isolates in an in vitro pharmacokinetic\/pharmacodynamic model with simulated endocardial vegetations","volume":"56","author":"Hall","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180702005751_CIT0029","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1592\/phco.31.6.527","article-title":"High-dose daptomycin for treatment of complicated gram-positive infections: a large, multicenter, retrospective study","volume":"31","author":"Kullar","year":"2011","journal-title":"Pharmacotherapy"},{"key":"key\n\t\t\t\t20180702005751_CIT0030","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1128\/AAC.33.4.470","article-title":"In vitro synergism between daptomycin and fosfomycin against Enterococcus faecalis isolates with high-level gentamicin resistance","volume":"33","author":"Rice","year":"1989","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180702005751_CIT0031","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0732-8893(92)90045-U","article-title":"In vivo activity of the combination of daptomycin and fosfomycin compared with daptomycin alone against a strain of Enterococcus faecalis with high-level gentamicin resistance in the rat endocarditis model","volume":"15","author":"Rice","year":"1992","journal-title":"Diagn Microbiol Infect Dis"},{"key":"key\n\t\t\t\t20180702005751_CIT0032","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1159\/000330458","article-title":"In vitro activity effects of twelve antibiotics alone and in association against twenty-seven Enterococcus faecalis strains isolated from Italian patients with infective endocarditis: high in vitro synergistic effect of the association ceftriaxone-fosfomycin","volume":"57","author":"Farina","year":"2011","journal-title":"Chemotherapy"},{"key":"key\n\t\t\t\t20180702005751_CIT0033","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.diagmicrobio.2013.07.012","article-title":"In vitro efficacy of fosfomycin-based combinations against clinical vancomycin-resistant Enterococcus isolates","volume":"77","author":"Tang","year":"2013","journal-title":"Diagn Microbiol Infect Dis"},{"key":"key\n\t\t\t\t20180702005751_CIT0034","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1046\/j.1469-0691.2001.00059.x","article-title":"Limitations of presently available glycopeptides in the treatment of gram-positive infection","volume":"7","author":"Ziglam","year":"2001","journal-title":"Clin Microbiol Infect"},{"key":"key\n\t\t\t\t20180702005751_CIT0035","doi-asserted-by":"crossref","first-page":"637","DOI":"10.2165\/00003495-199753040-00007","article-title":"Fosfomycin tromethamine. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy as a single-dose oral treatment for acute uncomplicated lower urinary tract infections","volume":"53","author":"Patel","year":"1997","journal-title":"Drugs"},{"key":"key\n\t\t\t\t20180702005751_CIT0036","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1128\/AAC.02583-12","article-title":"Activities of fosfomycin and rifampin on planktonic and adherent Enterococcus faecalis strains in an experimental foreign-body infection model","volume":"58","author":"Oliva","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180702005751_CIT0037","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1128\/AAC.00131-07","article-title":"Time-kill and synergism studies of ceftobiprole against Enterococcus faecalis, including beta-lactamase-producing and vancomycin-resistant isolates","volume":"51","author":"Arias","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180702005751_CIT0038","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/jac\/dkr477","article-title":"Effectiveness of ciprofloxacin or linezolid in combination with rifampicin against Enterococcus faecalis in biofilms","volume":"67","author":"Holmberg","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20180702005751_CIT0039","doi-asserted-by":"crossref","first-page":"4612","DOI":"10.1128\/AAC.02790-13","article-title":"Activity of daptomycin or linezolid in combination with rifampin or gentamicin against biofilm-forming Enterococcus faecalis or E. faecium in an in vitro pharmacodynamic model using simulated endocardial vegetations and an in vivo survival assay using Galleria mellonella larvae","volume":"58","author":"Luther","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180702005751_CIT0040","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1007\/s10096-011-1498-1","article-title":"In vitro activity and in vivo efficacy of tigecycline alone and in combination with daptomycin and rifampin against gram-positive cocci isolated from surgical wound infection","volume":"31","author":"Silvestri","year":"2012","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"8","key":"key\n\t\t\t\t20180702005751_CIT0041","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1093\/jac\/dkv125","article-title":"The combination of ampicillin plus ceftaroline is synergistic against Enterococcus faecalis","volume":"70","author":"Werth","year":"2015","journal-title":"J Antimicrob Chemother"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/67\/2\/303\/25103152\/ciy064.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,13]],"date-time":"2022-08-13T04:34:40Z","timestamp":1660365280000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/67\/2\/303\/4829420"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,30]]},"references-count":41,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2018,1,30]]},"published-print":{"date-parts":[[2018,7,2]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciy064","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,7,15]]},"published":{"date-parts":[[2018,1,30]]}}}